Clin Lung Cancer.2020 Jun;S1525-7304(20)30205-9. doi: 10.1016/j.cllc.2020.06.011.Epub 2020-06-18.
RET融合陽性の非定型肺カルチノイド患者における選択的RET阻害薬セルペルカチニブ（LOXO-292）の効果
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid.
- Elizabeth M Kander
- Manisha H Shah
- Ye Zhou
- Ashima Goyal
- Joshua D Palmer
- Dwight H Owen
- Konstantin Shilo
- Gopal Patel
- Raju R Raval
- Javier Gonzalez
- Michele Nguyen
- Elizabeth Olek
- Jennifer Kherani
- S Michael Rothenberg
- Bhavana Konda
PMID: 32660930 DOI: 10.1016/j.cllc.2020.06.011.
抄録
抄録はありません
